Cite
Targeting Myeloid Differentiation Using Potent 2‑Hydroxypyrazolo[1,5‑a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
MLA
Sainas, Stefano, et al. “Targeting Myeloid Differentiation Using Potent 2‑Hydroxypyrazolo[1,5‑a]Pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.” Journal of Medicinal Chemistry, vol. 61, no. 14, July 2018, pp. 6034–55. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.8b00373.
APA
Sainas, S., Pippione, A. C., Lupino, E., Giorgis, M., Circosta, P., Gaidano, V., Goyal, P., Bonanni, D., Rolando, B., Cignetti, A., Ducime, A., Andersson, M., Järvå, M., Friemann, R., Piccinini, M., Ramondetti, C., Buccinnà, B., Al-Karadaghi, S., Boschi, D., & Saglio, G. (2018). Targeting Myeloid Differentiation Using Potent 2‑Hydroxypyrazolo[1,5‑a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. Journal of Medicinal Chemistry, 61(14), 6034–6055. https://doi.org/10.1021/acs.jmedchem.8b00373
Chicago
Sainas, Stefano, Agnese C. Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, et al. 2018. “Targeting Myeloid Differentiation Using Potent 2‑Hydroxypyrazolo[1,5‑a]Pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.” Journal of Medicinal Chemistry 61 (14): 6034–55. doi:10.1021/acs.jmedchem.8b00373.